HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EWG Casts FDA’s Proposed Sunscreen Rule As Validation Of Longstanding Concerns

Executive Summary

The Environmental Working Group has long favored mineral over chemical sunscreens in its annual ratings and buying guide, with particular concerns about oxybenzone, one of 12 active ingredients that FDA says need additional safety data to support GRASE determinations.

You may also be interested in...

FDA’s Sunscreen Regulatory Approach Misaligned With Its Public Health Messaging, Trade Groups Say

The Personal Care Products Council and Consumer Healthcare Products Association say FDA’s tentative final sunscreen monograph and related communications have given rise to confusion that could lead to reduced sunscreen use and negative public health consequences. The groups go one further: FDA should reissue a tentative final monograph proposing that the 12 chemical UV filters currently in question are GRASE.

EWG Asks CDC To Add Sunscreen Ingredients To National Biomonitoring Program

The US Centers for Disease Control and Prevention should “diligently” track systemic exposure to the 12 UV filters currently in question at FDA, the Environmental Working Group says in a recent petition.

Consumer Reports Issues 2019 Sunscreen Recommendations; All Contain Oxybenzone

While acknowledging concerns about oxybenzone, Consumer Reports maintains the importance of sunscreen to help prevent skin cancer and says oxybenzone-containing offerings continue to test best when it comes to broad-spectrum protection and minimal SPF “variation.”

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts